Spots Global Cancer Trial Database for lgh447,
Every month we try and update this database with for lgh447, cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma | NCT02144038 | Relapsed and Re... | LGH447 BYL719 | 18 Years - | Novartis | |
Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma | NCT02144038 | Relapsed and Re... | LGH447 BYL719 | 18 Years - | Novartis | |
A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) | NCT02078609 | AML and High Ri... | LGH447 LGH447 + midost... | 18 Years - | Novartis |